Factors associated with local recurrence in operated osteosarcomas: A retrospective evaluation of 95 cases from a tertiary care center in a resource challenged environment. Issue 5 (25th April 2017)

• Record Type: Journal Article
• Authors: Poudel, Rishi R.; Tiwari, Vivek; Kumar, Venkatesan S.; Bakhshi, Sameer; Gamanagatti, Shivanand; Khan, Shah Alam; Rastogi, Shishir
• Other Names: Kingham T. Peter guestEditor.; Are Chandra guestEditor.
• Is Part Of: Journal of surgical oncology. Volume 115:Issue 5(2017)
• Page Start: 631
• Page End: 636
• Publication Date: 2017-04-25
• Subjects: biopsy -- delay in surgery -- developing world; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.24602
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract : BACKGROUND AND OBJECTIVES: Local control of disease is one of the main goals of osteosarcoma management. We conducted a retrospective evaluation of 95 operated cases of osteosarcoma over 7 years to know about the factors associated with local recurrence in resource‐challenged environment of the developing world. METHODS: The factors which were evaluated and compared between local recurrence and non‐local recurrence groups included demographic profile, site of tumor, whether biopsy done outside, type of surgery (limb salvage or amputation), presence of pathological fracture, vicinity of neurovascular bundle, tumor volume, histological subtype, chemotherapy induced necrosis, surgical margins, and delay in surgery. The time to local recurrence after surgery was also noted in the local recurrence group. RESULTS: At a mean follow‐up of 2.8 years, biopsy done from outside the treating center and delay in surgery after completion of neo‐adjuvant chemotherapy emerged as significant risk factors for local recurrence. Most of the local recurrences (80%) occurred within 12 months of the primary surgery. CONCLUSIONS: Lack of financial resources and availability of few tertiary care centers dealing with musculoskeletal oncology in the developing countries, lead to overburden with a long waiting list for tumor surgery making the scenario different from the Western world.